Partin AW - Search Results

1

Effect of DNA methylation on identification of aggressive prostate cancer.

Alumkal JJ, Zhang Z, Humphreys EB, Bennett C, Mangold LA, Carducci MA, Partin AW, Garrett-Mayer E, DeMarzo AM, Herman JG. Alumkal JJ, et al. Among authors: partin aw. Urology. 2008 Dec;72(6):1234-9. doi: 10.1016/j.urology.2007.12.060. Epub 2008 Apr 2. Urology. 2008. PMID: 18387661 Free PMC article.

2

Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.

Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC. Epstein JI, et al. J Urol. 1992 Jul;148(1):87-91. doi: 10.1016/s0022-5347(17)36518-7. J Urol. 1992. PMID: 1613888 Free article. Review.

3

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

4

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. Among authors: partin aw. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

5

Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.

Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Partin AW, et al. J Urol. 1989 Feb;141(2):341-5. doi: 10.1016/s0022-5347(17)40761-0. J Urol. 1989. PMID: 2913356

6

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.

Partin AW, Pearson JD, Landis PK, Carter HB, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Partin AW, et al. Urology. 1994 May;43(5):649-59. doi: 10.1016/0090-4295(94)90180-5. Urology. 1994. PMID: 7513108

7

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

Partin AW, Walsh PC. Partin AW, et al. J Urol. 1994 Jul;152(1):172-3. doi: 10.1016/s0022-5347(17)32852-5. J Urol. 1994. PMID: 7515450 No abstract available.

8

The clinical usefulness of prostate specific antigen: update 1994.

Partin AW, Oesterling JE. Partin AW, et al. J Urol. 1994 Nov;152(5 Pt 1):1358-68. doi: 10.1016/s0022-5347(17)32422-9. J Urol. 1994. PMID: 7523702 Free article. Review.

9

Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.

Walsh PC, Partin AW, Epstein JI. Walsh PC, et al. Among authors: partin aw. J Urol. 1994 Nov;152(5 Pt 2):1831-6. doi: 10.1016/s0022-5347(17)32396-0. J Urol. 1994. PMID: 7523730 Free article.

10

Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.

Cadeddu JA, Pearson JD, Lee BR, Landis P, Partin AW, Epstein JI, Carter HB. Cadeddu JA, et al. Among authors: partin aw. Urology. 1995 May;45(5):795-800. doi: 10.1016/s0090-4295(99)80086-7. Urology. 1995. PMID: 7538241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

613 results

Search Page